Translated to IBD patients this may explain why some patients achieve mucosal healing and others do not, after receiving the same anti-TNF agent, neutralizing one of the driving forces and upstream regulators of IL13RA2 expression (5). This evidence concerns the gene IL13RA2 and inflammatory bowel disease.